Branched Chain Aminoacid Supplementation in Patients With Liver Cirrhosis
High-fiber High-fiber Diet and Branched Chain Aminoacids. Impact on Nutritional Status and Complications in Patients With Liver Cirrhosis
1 other identifier
interventional
68
1 country
1
Brief Summary
Malnutrition is a frequent complication in patients with liver cirrhosis. Most patients have decreased dietary intake due to ascites, hepatic encephalopathy and pro-inflammatory cytokines. We hypothesized that branched chain aminoacids can improve nutritional status and delay episodes of hepatic encephalopathy
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Jan 2011
Typical duration for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2013
CompletedFirst Submitted
Initial submission to the registry
December 23, 2013
CompletedFirst Posted
Study publicly available on registry
December 30, 2013
CompletedDecember 30, 2013
December 1, 2013
2 years
December 23, 2013
December 23, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Nutritional status
Assessed by bioelectrical impedance vector analysis and mid-arm muscle circumference
At time of recruitment
Secondary Outcomes (1)
Hepatic Encephalopathy
At time of recruitment
Other Outcomes (3)
Nutritional status
3 months follow-up
Nutritional status
6 months follow-up
Hepatic encephalopathy
6 months follow-up
Study Arms (2)
Diet plus branched chain aminoacids
EXPERIMENTALHigh-fiber high-protein diet Oral supplement : branched chain aminoacids
Diet
ACTIVE COMPARATORHigh-fiber high-protein diet
Interventions
Eligibility Criteria
You may qualify if:
- Ambulatory patients Patients with confirmed diagnose of liver cirrhosis Patients classified as Child-Pugh A or Child Pugh B
You may not qualify if:
- Acute or chronic renal failure Pregnancy Overt hepatic encephalopathy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán"
Mexico City, 14000, Mexico
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
December 23, 2013
First Posted
December 30, 2013
Study Start
January 1, 2011
Primary Completion
January 1, 2013
Study Completion
May 1, 2013
Last Updated
December 30, 2013
Record last verified: 2013-12